These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2035 related articles for article (PubMed ID: 15573398)
1. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398 [TBL] [Abstract][Full Text] [Related]
2. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996 [TBL] [Abstract][Full Text] [Related]
3. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Nagai M; Sato N Biochem Biophys Res Commun; 1999 Apr; 257(3):719-23. PubMed ID: 10208850 [TBL] [Abstract][Full Text] [Related]
4. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H; Guo J; Bringhurst FR J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438 [TBL] [Abstract][Full Text] [Related]
6. RANKL expression is related to the differentiation state of human osteoblasts. Atkins GJ; Kostakis P; Pan B; Farrugia A; Gronthos S; Evdokiou A; Harrison K; Findlay DM; Zannettino AC J Bone Miner Res; 2003 Jun; 18(6):1088-98. PubMed ID: 12817763 [TBL] [Abstract][Full Text] [Related]
7. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673 [TBL] [Abstract][Full Text] [Related]
8. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804 [TBL] [Abstract][Full Text] [Related]
10. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054 [TBL] [Abstract][Full Text] [Related]
12. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation. Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498 [TBL] [Abstract][Full Text] [Related]
13. Regulation of osteoclastogenesis by gap junction communication. Matemba SF; Lie A; Ransjö M J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710 [TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342 [TBL] [Abstract][Full Text] [Related]
16. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells. Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200 [TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166 [TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085 [TBL] [Abstract][Full Text] [Related]
19. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. Faucheux C; Horton MA; Price JS J Bone Miner Res; 2002 Mar; 17(3):455-64. PubMed ID: 11874237 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]